Press Releases from Greystone Research Associates (106 total)
Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key…
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace…
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device…
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly…
For Injectable Drugs Wireless Connectivity Allows Caregivers to Manage Patients …
(Amherst, NH) – The growing emphasis on drug self-administration is having a major impact on the pharmaceutical industry. The aging population and managed care initiatives…
Responding to Competitive Factors Drug Injection Device Suppliers Continue to In …
(Amherst, NH) – As pharmaceutical companies struggle to position their products in the direct-to-consumer marketing era, the trend toward combining functionality and packaging in drug…
Biological Autoimmune Therapeutics Continue to Grow as Patients and Caregivers S …
(Amherst, NH) – The administration of therapeutic immune modulators is becoming an increasingly important healthcare treatment option for a growing number of diseases and indications…
Uptake of Autoimmune Injectables Aided by Delivery Device Evolution
(Amherst, NH) – Autoimmune diseases, a group of chronic ailments that includes arthritis, psoriasis, lupus, and multiple sclerosis, afflict tens of millions of people worldwide…
Patient Enablement and Immunotherapeutic Drug Self-Dosing
(Amherst, NH) – The administration of therapeutic immune modulators is becoming an increasingly important healthcare treatment option for a growing number diseases and indications having…
Injection Device Design Evolution a Key to the Growth of Biological Drugs
(Amherst, NH) – Because of their ability to effectively treat refractory conditions by targeting specific biomarkers, biological drugs continue to be at the forefront of…
Handheld Devices for Injecting Viscous Drugs Becoming a Defined Market
(Amherst, NH) – The high value, proliferation and properties of biological drugs are creating opportunities and challenges for device developers. In particular, sector participants are…
Sustained Release Injectable Drugs Filling an Unmet Need by Extending Dosing Int …
(Amherst, NH) - For many chronic and refractory conditions, the need for frequent and continual drug injections is a therapeutic necessity, one that can…
Unprecedented Market Exits a Reality Check for Measuring Glucose Noninvasively
(Amherst, NH) – Very few medical device markets can claim to exceed noninvasive glucose monitors (NGM) for marketing hype, product pronouncements and unkept promises. Fueled…
Strategies for Injectable Drug Managers Require Multidimensional Metrics as Mark …
(Amherst, NH) – There are currently over 1,900 approved injectable drugs across all application types (BLA/NDA/ANDA). Approved injectable drug applications have been average 70 per…
On-Body Subcutaneous Injection Systems Positioned to Prosper as Dosage Volumes P …
(Amherst, NH) – As drug developers widen the therapeutic envelope to create effective treatments for intractable disease targets, they are finding it necessary to move…
Dual Chamber Injection Device Market to Reach $5.3 Billion by 2024
(Amherst, NH) – The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients…
Converging Factors Driving the Growth of Transdermal Patches for Neurology Indic …
(Amherst, NH) – Despite recent progress in a number of therapeutic sectors, progress toward curative medicine for neurological and related central nervous system disorders has…
Microchips Accelerating the Evolution of Drug Device Sophistication
(Amherst, NH) - As therapeutic drug markets continue to evolve, advancements in drugs and devices are producing several positive improvements. New formulations are extending drug…
Unmet Need Remains for Subcutaneous Sustained Release Injectables
(Amherst, NH) - As patients live longer and the prevalence and incidence of chronic ailments increase across the general population, drug developers and their…
Drug Developers Look to Deuterated Drugs as Risk Managed Opportunity
(Amherst, NH) – Interest in deuterated drugs – drugs in which carbon-hydrogen bonds have been replaced with carbon-deuterium (heavy hydrogen) bonds - has been increasing…
Closed Transfer Systems for Hazardous Drugs Preparing for Change as New Standard …
(Amherst, NH) – In the specialized area of oncology, the use of substances that can harm as well as benefit is common. The danger extends…
As Self Administered Injectables Expand Drug Companies Attempt to Capture the Pa …
(Amherst, NH) – The rapidly increasing number of drugs being developed for administration through the skin is fostering a growing supply chain infrastructure for injectable…
Converging Factors Driving the Growth of Dry Powder Inhaled Delivery
(Amherst, NH) – The search for improved routes of administration for therapeutic agents and the desire for noninvasive delivery methods for self-medication of chronic conditions…
Wearable Patch Pumps that Deliver Drugs Subcutaneously Filling an Unmet Need
(Amherst, NH) – As the number of patients diagnosed with chronic diseases continues to grow, the pharma and biotech industries are rising to address the…
Generic Oral Liquid Drug Dosage Forms Evolving as Competitors Seek Opportunities
(Amherst, NH) – The generic oral liquid dosage form drug segment is a rapidly evolving and fluid environment that has been a challenge to decision…
As the Industry Evolves the Recombinant Drug Sourcing Landscape Reflects Pragmat …
(Amherst, NH) – In recent years, the number of biological drugs - approved and in development - has increased significantly. The pace of this growth…
Vaccines Delivered by Microneedles to Reach $440 Million by the End of the Decad …
(Amherst, NH) – The global market for microneedle-delivered prophylactic vaccines reached US $210 million in 2016 and is expected to increase 20 percent annually, exceeding…
Handheld Devices that Target High Viscosity Drugs Expected to Benefit from Biolo …
(Amherst, NH) - As biologicals continue to dominate the drug development landscape, their impact on the healthcare industry is beginning to be felt in unexpected…
Wirelessly Enabled Injection Devices Keep Patients Connected to Caregivers as Ho …
(Amherst, NH) – As the number of patients who self-administer injectable drugs continues to grow, adherence to drug therapy and disease management protocols have become…
Infusion Medication Management Systems a Key Initiative for Improving Patient Sa …
(Amherst, NH) – Infusion is one of the most common in-patient procedures. So perhaps it’s not surprising that infusion devices are the subject of more…
Despite Progress Injectable/Infusible Antimetabolites Remain the Workhorse in Ca …
(Amherst, NH) – The world of oncology continues to evolve as physician specialists and researchers apply the latest knowledge and therapies to treat…
Despite Research Efforts Ten Injectable APIs Continue to Anchor the Injectable A …
(Amherst, NH) – For many chronic and refractory conditions, the need for frequent and continual drug injections is a therapeutic necessity, one that…
Despite Incremental Improvements, the Promise of Smart Infusion Remains an Elusi …
(Amherst, NH) – Infusion remains one of the most common in-patient procedures and a technology that has been around for decades, yet the nature of…
Connected Drug Delivery Represents a New Element in Personalized Medicine
(Amherst, NH) – Wireless technologies for drug delivery have been explored in novel platforms for the past decade. But it’s only been recently that wireless…
Transdermal Prescription Gels Finding Opportunity in Niche Aging Markets
(Amherst, NH) – There are currently more than three dozen approved transdermal prescription gel drug products. Transdermal gel systems for delivering systemic therapeutics are attractive…
Collaborations and Alliances Increasing as the Market for Prefilled Syringes Mat …
(Amherst, NH) – The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now…
Generic Solid Dosage Forms Maintain their Rapid Rate of Expansion
(Amherst, NH) – Generic drugs are re-shaping the pharmaceutical industry, and the pace of activity shows no signs of slowing. Nowhere is the rate of…
Connected Oral Inhalers Latest Attempt to Improve Patient Self-Administration of …
(Amherst, NH) – Upper respiratory tract (URT) conditions including asthma and chronic obstructive pulmonary disease (COPD) continue to be a health segment that presents challenges…
Propelled by Innovative Devices Patient Self-Administration is Transforming the …
(Amherst, NH) – Rapid changes in the therapeutic drug sector are challenging pharmaceutical developers in a number of functional areas. In this mix are the…
As Therapeutic Protein Market Grows, the Importance of Point-of-Care Strategies …
(Amherst, NH) – Led by the proliferation of antibody-based drugs and candidates, biological drugs as a class continue to outpace all other NCEs in development…
Immune Modulators Continue to Dominate the Recombinant Drug Landscape
(Amherst, NH) – The role of the immune system in maintaining human health and disease prevention is now understood to include its impact on numerous…
Injection Device Suppliers Introducing New Designs at a Record Pace
(Amherst, NH) – The proliferation of syringes and injectors for administering injectable drugs is occurring at a rate that is unprecedented in the history of…
Drug Companies Re-positioning Intravenous Drugs for Subcutaneous Delivery
(Amherst, NH) – The number of drugs based on biologicals continues to grow at an increasingly rapid rate. Because of their physical properties and the…
Small Form Factor Device Simplicity Propelling the Adoption of Self-administered …
(Amherst, NH) – In terms of developer interest and market activity, small form factor subcutaneous infusion (SFFSI) devices are reaching a tipping point that is…
Microneedles Pursuing Patient Monitoring and Diagnostics Markets
(Amherst, NH) – Microneedle technology is attaining commercial viability at a time when healthcare providers are faced with new challenges as they assess ways to…
As Therapeutics and Demographics Converge Developers Seek to Deliver Drugs in Hi …
(Amherst, NH) – As the trend favoring biological drugs as a percent of all drugs continues, the number of injectables that exceed 1 mL per…
Integrated Devices for Reconstituting Injectables Creating Options for Drug Deve …
(Amherst, NH) – Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they…
Pace of Change Makes the Market for Generic Injectables a Moving Target
(Amherst, NH) – Along with the ability to create therapeutic replicas of biochemicals via host systems, the emergence and proliferation of generic drugs continue to…
Connected Skin Patches Ushering in a New Era of Personal Data
(Amherst, NH) – The ability to monitor movement, position, processes, physical parameters, analytes, and orientation using low-cost electronics in a small package that self-attaches to…
Sustained Release Injectable Drugs Filling an Unmet Need by Extending Dosing Int …
(Amherst, NH) - For many chronic and refractory conditions, the need for frequent and continual drug injections is a therapeutic necessity, one that can…
Go To Page: 1 2
